Comment on: What goes between the name and the thing: should we rethink VEGF denomination in preeclampsia?

By Henao Daniel E.  

Hypertension in Pregnancy, Vol. 31, Iss. 4, 2012-11 ,pp. : 387-388

Informa Healthcare

Access to resources Recommend Favorite

Informed decision-making about the fetal anomaly scan: what knowledge is relevant?

By Schoonen H. M. H. J. D.   Essink-Bot M. L.   Van AGT H. M. E.   Wildschut H. I.   Steegers E. A. P.   De Koning H. J.  

Ultrasound in Obstetrics and Gynecology, Vol. 37, Iss. 6, 2011-06 ,pp. : 649-657

John Wiley & Sons Inc

Access to resources Recommend Favorite

Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel?

By Rosa Maria Inês  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 2, 2013-04 ,pp. : 137-139

Informa Healthcare

Access to resources Recommend Favorite

Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? A reply to Rosa et al .

By Martínez Francisca  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 2, 2013-04 ,pp. : 139-142

Informa Healthcare

Access to resources Recommend Favorite

Thyroid disease and gestational diabetes mellitus (GDM): is there a connection?

By Stohl Hindi E.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 26, Iss. 11, 2013-07 ,pp. : 1139-1142

Informa Healthcare

Access to resources Recommend Favorite